{"id":"NCT04508309","sponsor":"PATH","briefTitle":"Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls","officialTitle":"Phase 3 Randomized, Active-Comparator Controlled, Open-Label Trial to Evaluate the Immunogenicity & Safety of Alternate 2-Dose Regimens of Cecolin® Compared to Gardasil® in 9-14 Year-Old Girls in Low and Low-Middle Income Countries","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-15","primaryCompletion":"2023-12-14","completion":"2023-12-14","firstPosted":"2020-08-11","resultsPosted":"2025-01-30","lastUpdate":"2025-01-30"},"enrollment":1025,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Cervical Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Cecolin®","otherNames":[]},{"type":"BIOLOGICAL","name":"Gardasil®","otherNames":[]}],"arms":[{"label":"Cecolin® at 0 and 6 months","type":"EXPERIMENTAL"},{"label":"Cecolin® at 0 and 12 months","type":"EXPERIMENTAL"},{"label":"Cecolin® at 0 and 24 months","type":"EXPERIMENTAL"},{"label":"Gardasil® at 0 and 6 months","type":"ACTIVE_COMPARATOR"},{"label":"Gardasil® at 0 and Cecolin® at 24 months","type":"OTHER"}],"summary":"This randomized controlled trial will evaluate a bivalent HPV vaccine, Cecolin®, in alternate 2-dose regimens, compared to an established HPV vaccine. Gardasil® will be used as the comparator vaccine, as this vaccine is most widely used in low- and low-middle income countries.","primaryOutcome":{"measure":"Geometric Mean Concentration (GMC) of Anti-HPV-16 Immunoglobulin G (IgG) Antibodies One Month After the Second Dose","timeFrame":"One month after the second dose (Month 7 for Groups 1 & 4, Month 13 for Group 2, and Month 25 for Groups 3 & 5).","effectByArm":[{"arm":"1. Cecolin at Month 0 and 6","deltaMin":1507.4,"sd":null},{"arm":"2. Cecolin at Month 0 and 12","deltaMin":2408.7,"sd":null},{"arm":"3. Cecolin at Month 0 and 24","deltaMin":3326.1,"sd":null},{"arm":"4. Gardasil at Month 0 and 6","deltaMin":1352.4,"sd":null},{"arm":"5. Gardasil at Month 0 and Cecolin at Month 24","deltaMin":2387.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG003","p":null},{"comp":"OG001 vs OG003","p":null},{"comp":"OG002 vs OG003","p":null}]},"eligibility":{"minAge":"9 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["Bangladesh","Ghana"]},"refs":{"pmids":["38431444","40120597"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":205},"commonTop":["Vaccination site pain","Headache","Cough","Myalgia","Upper respiratory tract infection"]}}